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E-mail address: kimkk@chonnam.ac.kr (K.K. Kim).KAI1 C-terminal interacting tetraspanin (KITENIN) is reported to promote metastasis in mouse colon
cancer models. We investigated the role of KITENIN on the progression of squamous cell carcinoma
(SCC). In a preliminary clinical study using resected tissues from head and neck SCC patients, KITE-
NIN was highly expressed in tumors and metastatic lymph nodes, while KAI1 was more increased in
adjacent mucosa than in tumor. KITENIN-transfected mouse squamous cancer (SCC VII/KITENIN)
cells showed signiﬁcantly higher invasion, migration, and proliferation than empty vector-transfec-
ted cells. In syngeneic mouse squamous tumor models, more increased tumor volume and enhanced
lung metastasis were found in SCC VII/KITENIN cells-injected mice. Thus, KITENIN increases invasion
and migration of squamous cancer cells and thereby promotes distant metastasis in mouse squa-
mous tumor models.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Malignant tumors remain a signiﬁcant cause of cancer related
death despite important developments in cancer treatment. There
have been many studies evaluating how best to reduce the pro-
gression and metastasis of cancer. Gene therapy targeting with
the goal of suppression of tumor metastasis is a promising method
of preventing metastatic disease because it aims to inhibit the
spread of cancer regardless of the tumorigenicity [1,2]. The pres-
ence of regional metastasis in patients with head and neck squa-
mous cell carcinoma (HNSCC) is a common adverse event
associated with poor prognosis and high mortality. Treatment or
prevention of HNSCC metastasis is a critical clinical point that re-
quires a full understanding of the molecular mechanisms of squa-
mous cancer cell invasion and dissemination [3].
KAI1, a tumor metastasis suppressor gene, is a transmembrane
glycoprotein that is a member of the tetraspanins and is down-chemical Societies. Published by E
ad and neck squamous cell
aspanin; SCC, squamous cell
ent of Pharmacology, Chon-
, Dong-Ku, Kwangju 501-190,regulated during the malignant progression of various cancers
[4–7]. It was recently found that the metastasis suppressor func-
tion was decreased in a spliced variant of KAI1 at the COOH-ter-
minal region; this result suggested that the COOH-terminal region
of KAI1 is important for the effects of KAI1 on cell motility [8].
Subsequently, via a yeast two-hybrid system, a protein that inter-
acted with the COOH-terminal cytoplasm domain of KAI1 was
identiﬁed [9]. This protein was found to be the Vang-like 1
(VANGL1) [10]; whose function has not fully understood in carci-
nogenesis and renamed as KAI1 C-terminal interacting tetra-
spanin (KITENIN). The KITENIN-overexpressing CT-26 mouse
colon cancer cells showed increased tumorigenicity and early he-
patic metastasis in vivo, as well as increased invasiveness and
adhesion to ﬁbronectin in vitro, compared with parental cells
[9]. Moreover, the suppression of progression and metastasis of
established colon cancer in mice was observed by intravenous
delivery of siRNA targeting KITENIN [11], and the functional KITE-
NIN/Dishevelled/PKCd complex controlled colorectal cancer (CRC)
cell invasion, which may contribute to promoting metastasis, as
an executor in regard to cell motility [12]. In addition, the expres-
sion of KITENIN, a tumor metastasis-enhancing gene, inversely
correlated with that of KAI1, a tumor metastasis suppressor gene,
in CT-26 mouse colon cancer cells [9] and some bladder cancer
cell lines [13].lsevier B.V. All rights reserved.
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mous cell carcinoma (SCC) has been reported until to date. There-
fore, based upon the work performed in a mouse colon cancer
model showing that KITENIN affects tumor cell migration and
metastasis when overexpressed, we evaluated the role of KITENIN
in the progression and distant metastasis of SCC by using speci-
mens from locally advanced HNSCC patients, and a murine squa-
mous cancer cells (SCC VII) and its syngeneic mouse squamous
tumor model.
2. Materials and methods
2.1. Assays of tumor tissues from HNSCC patients
The malignant tumors and adjacent mucosal tissues were ob-
tained from 17 patients in which 8 and 9 samples were used for to-
tal RNA and protein preparation, respectively; six patients from
recurrent supraglottic cancer after chemotherapy and radiation
therapy (T3N0), ﬁve patients from recurrent glottic cancer after
radiation therapy (T1bN0), four patients from supraglottic cancer
(T4aN2b), and two patients from recurrent hypopharyngeal cancer
after radiation therapy (T3N2c). For analysis of metastasis, meta-
static and non-metastatic lymph nodes (n = 6) were obtained pa-
tients from supraglottic cancer (T4aN2b) and patients from
recurrent hypopharyngeal cancer after radiation therapy (T3N2c).
The Ethics Committee at Chonnam National University Hospital
approved our experimental protocols.
Western blot analysis was used to investigate KITENIN expres-
sion in the obtained tissues. The resolved proteins (50 lg) were
transferred to a nitrocellulose membrane and blotted with the
KITENIN antibody and anti-rabbit immunoglobulin-horseradish
peroxidase as described previously [9]. The blot was reprobed with
anti-actin antibody (I-19; Santa Cruz Biotechnology, Santa Cruz,
CA) as a loading control.
2.2. Cell culture, transfection and RT-PCR
The mouse SCC VII cell line was grown in RPMI 1640 (Hyclone,
Logan, UT) supplemented with 10% fetal bovine serum (Hyclone) at
37 C. The cDNA of human KITENIN and the vector only were trans-
fected into the SCC VII cells. The transfections were performed as
described previously [8]. Cells were detached using 0.25% tryp-
sin-EDTA solution (Invitrogen, Grand Island, NY) and passed into
the selective media containing 5 lg/ml blasticidin (Invitrogen).
Two weeks later, the surviving clones were evaluated by Western
blot analysis for the expression of the KITENIN protein, and mixed
polyclonal cells were used for further analyzes.
Total RNAswere prepared from the adjacentmucosal tissues and
malignant tumors of 8 HNSCC patients (four T3N0 and four T1bN0),
and non-metastatic and metastatic lymph nodes of 4 HNSCC
patients (twoT4aN2band twoT3N2c), and theKITENIN- andvector-
transfected SCC II cells as described previously [8]. RT-PCR exponen-
tial phase was determined to be 32 cycles; this allowed for a
quantitative comparison of each cDNA from identical reactions. All
of the reactions involved an initial denaturation at 94 C for 5 min
followed by 32 cycles at 94 C for 50 s, at 58 C for 50 s, and 72 C
for 60 s usingPCRprimers The ampliﬁcation productswere analyzed
on agarose gels and visualized by UV epiﬂuorescence. The sequence
of primers are as follows: KITENIN, forward 50-CTACAATGTA-
GATGGCCCC-30/reverse 50-AGCCTCATCACTGACAAGCC-30; MMP-1,
forward 50-TTGGGCTGAAAGTGACTGG-30/reverse 50-CCTCCAT-
TACCTGGGCCTGG-30; COX-2, forward 50-GCATTCTTTGCCCAGC-
ACTT-30/reverse 50-AGACCAGGCACCAGACCAAAG-30; CD44,
forward 50-ATGGACAAGTTTTGGTGCAC-30/reverse 50-CTTCTAT-
GAACCCATACCTGC-30; CyclinD1, forward 50-GACCATCCCCCTGACG
GCCGAG-30/reverse 50-CCGCACGTCGGTGGGTCTGC-30.2.3. Cell invasion assay
Cell invasion was measured using a Transwell migration appa-
ratus (Costar Inc., Cambridge, United Kingdom) with minor modi-
ﬁcation as described previously [8]. To start the assay, 2.4  105
cells (120 ll) were loaded onto the upper chamber of the Trans-
well, whereas 400 ll RPMI 1640/0.2% BSA containing 10 lg/ml or
20 lg/ml human plasma ﬁbronectin (Calbiochem, La Jolla, CA), a
chemotactic factor, were loaded onto the lower chamber. The
apparatus was incubated for 24 h at 37 C. The cells on the top sur-
face of the ﬁlters were wiped off with cotton balls, and the cells
that migrated, on the bottom surface, were counted in six random
squares of 0.5  0.5 mm2 on the microscope ﬁeld of view. The re-
sults were expressed as the mean ± SE of the number of cells/ﬁeld.
2.4. Cell migration assay
KITENIN-transfected and vector-transfected SCC VII cells were
seeded in a 6 well plate (1  106 cells/well). Twenty-four hours la-
ter, the media was changed to serum-free RPMI 1640 and incu-
bated for 12 h. After the media was removed from the wells, a
straight transverse line through the adherent cells was drawn
using a ruler and a 1000 ll-tip, resulting a uniform gap. The media
was changed to RPMI 1640 supplemented with 2% fetal bovine ser-
um. At 6, 12, 24, and 48 h later, the distances between the gaps
were measured in centimeters after capture of six random sites
in the microscope ﬁelds.
2.5. Cell proliferation assay
Proliferation of the cells was measured as described previously
[8]. Cells were seeded at 1  104 cells/well in 24-well plates and
grown for 3 days in the presence of serum. Next the 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reagent was
added for 2 h, after which, the DMSO was added. The absorbance
at 570 nm was determined 16 h later using a microplate reader
with SOFTmax PRO software (Molecular Devices, Sunnyvale, CA).
The data were adjusted to the ﬁrst value of each group.
2.6. In vivo tumor growth
Prior approval of the experimental protocol was obtained from
the Chonnam National University Medical School Research Institu-
tional Animal Care and Use Committee. Maintenance of animals
and all in vivo experiments were performed according to the Guid-
ing Principles in the Care and Use of Animals. Subconﬂuent SCC VII
cells (KITENIN-transfected and vector-transfected) were trypsini-
zed and then suspended in RPMI 1640. The cell suspension
(1  106 cells in 0.1 ml medium/mouse) was injected subcutane-
ously into the right ﬂank of eight-week old, female, C3H/HeJ synge-
neic mice (n = 6 for each group). The tumor size was measured
daily with a vernier caliper from the third day to the fourth week
after injection. The tumor volume (V) was calculated using the val-
ues of the largest (A) and the smallest (B) diameter according to the
formula: V = 0.5  AB2.
During the ﬁfth week after injection, the presence of metastasis
in the lung and liver tissues from each mouse bearing a tumor
mass on the back was evaluated by gross and microscopic exami-
nation. The tissue sections were deparafﬁnized, rehydrated, and
rinsed. They were stained with H & E and examined for metastatic
nodules and cell pathology.
2.7. Statistical analysis
Experimental differences were tested for statistical signiﬁcance
with SPSS 12.0 (Microcal Software Inc., USA). ANOVA and the Stu-
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P-values of less than 0.05 were considered statistically signiﬁcant.3. Results
3.1. Increased KITENIN expression in the tumors and metastatic lymph
nodes from HNSCC patients, while KAI1 is more increased in adjacent
normal mucosa than in tumor
At ﬁrst, in 8 HNSCC patients studied, KITENIN mRNA expres-
sions were increased in the malignant tumors than in adjacent
mucosal tissues, but signiﬁcantly elevated in metastatic lymph
nodes compared with non-metastatic lymph nodes (Fig. 1A).
Next, in 9 HNSCC patients studied, KITENIN protein expressions
were increased in the malignant tumors and signiﬁcantly higher
in metastatic lymph nodes than in adjacent mucosal tissues and
non-metastatic lymph nodes, respectively (Fig. 1B and C). In addi-
tion, as previously reported [9,14–16], the expression of KAI1 in-
creased in adjacent normal mucosa more than in tumor, but
unexpectedly exhibited an elevated level in metastatic lymph
nodes (Fig. 1B and D). This observation suggests that the expres-
sion level of KITENIN is much better molecular marker for both
the malignant tumor and the metastatic lymph nodes of HNSCC
patients than that of KAI1. Moreover, it was suggested that the
KAI1 gene may not be a useful predictor of prognosis of oral
SCC, although decreased KAI1 expression may be associated with
increased invasive ability of oral SCC [15]. Overall, these prelimin-
ary clinical data from 17 HNSCC patients strongly suggest that
KITENIN expression is involved in the progression of SCC. There-
fore, we tried to prove this proposal through in vitro assays using
mouse SCC VII cells and in vivo assay using a mouse SCC tumor
model.
3.2. Increased invasion, migration and proliferation in KITENIN-
transfected squamous cancer cells
At ﬁrst, to establish squamous carcinoma cells stably expressing
KITENIN, SCC VII cells were stably transfected with pcDNA-
KITENIN cDNA or empty vector alone. KITENIN expression in mixed
clones following selection was then evaluated by Western blot
analysis, showing that KITENIN expression was higher in the KITE-
NIN-transfected SCC VII cells, whereas KITENIN was barely de-
tected in the empty vector-transfected SCC VII cells (Fig. 2A).
Therefore, polyclonal cells that were employed for omitting prob-
lematic clonal variation were subject to further functional assay.
Next, we examined whether overexpressed KITENIN affects on
cell invasion of SCC II cells. The number of invading vector-
transfected SCC VII cells were 65.0 ± 40.6, whereas for the KITE-
NIN-transfected SCC VII cells they were 158.8 ± 15.8 as measured
by the six random squares of the 0.5  0.5 mm2 microscope ﬁelds
under conditions of 10 lg/ml ﬁbronectin; the difference between
the two was statistically signiﬁcant (P = 0.004). In addition, under
the increasing dose of ﬁbronectin (20 lg/ml), the invading cells
were 172.0 ± 18.9 in the vector-group and 212.8 ± 24.2 in the KITE-
NIN-group (P = 0.009) (Fig. 2B). We also tested whether overex-
pressed KITENIN affects on cell migration of SCC II cells. The
artiﬁcial wound gap became signiﬁcantly narrower in the KITE-
NIN-group as time passed by 12, 24, and 48 h, compared with
the empty vector-group (P = 0.002) (Fig. 2C). In the KITENIN-group,
the gap was completely ﬁlled within 48 h, indicating that cell
migration was increased in KITENIN-transfected SCC VII cells.
Moreover, the proliferating cells, as determined by the absorbance,
were signiﬁcantly increased in the KITENIN-group compared to the
empty vector-group on the second and third day of measurement
(P < 0.05) (Fig. 2D).3.3. KITENIN positively affects on in vivo tumor growth and distant
metastasis in a syngeneic mouse squamous tumor model
Transfected SCC VII cells were injected subcutaneously into the
right ﬂank of syngeneic mice and at 6 days after injection, the tu-
mors were large enough to measure. The average tumor size was
signiﬁcantly larger in the KITENIN-group than in the empty vec-
tor-group during the time period measured after 12 days following
injection (P < 0.01) (Fig. 3A). Next, we examined whether overex-
pressed KITENIN in SCC VII cells promotes the distant metastasis
in a mouse squamous tumor model. Lung and liver tissue samples
were obtained from the vector-group (n = 6) or KITENIN-group
(n = 6). Pulmonary metastases were observed in lung tissues of 2
out of 6 mice from the vector-group and the number of metastatic
nodule is 0.5 ± 0.34/mouse. In contrast, in the KITENIN-group, met-
astatic nodules were observed in lung tissues of 4 from 6 mice and
the number of metastatic nodule was signiﬁcantly increased
(13 ± 5.3/mouse) more than that of vector-group (Fig. 3B). How-
ever, no liver metastases were observed in both groups. The
pathology of metastasized lung tissue demonstrated the tumor cell
nests invading the pleura and alveoli, and also dyskeratosis, fre-
quent mitosis, coarse chromatin, and nuclear pleomorphism were
found in high-power ﬁeld of pleural metastatic tissue, indicating
a presence of metastatic squamous tumor in lung tissue (Fig. 3C).
3.4. Increased expression of AP-1 target genes in KITENIN-transfected
squamous cancer cells
Recently, a functional KITENIN complex was reported to en-
hance migration and invasion of intestinal epithelial and CRC cells
in an ERK/AP-1-dependent manner [12]. To investigate the rela-
tionship between KITENIN and AP-1 axis in squamous cancer cells,
some well-known AP-1 target genes were compared between the
KITENIN- and empty vector-transfected SCC VII cells, such as cyclin
D1, MMP-1, COX-2, and CD44 [17–19]. The mRNAs of all of the
investigated AP-1 target genes were highly expressed in KITE-
NIN-transfected SCC VII cells (Fig. 4), indicating the positive
relationship between KITENIN and AP-1 axis in squamous cancer
cells.
4. Discussion
The KITENIN/VANGL1 gene is located on human chromosome
1p13. Abnormalities in this 1p13 region have been reported in
head and neck cancer, breast cancer and Kaposi’s sarcoma
[20–22]. In addition, a putative prostate cancer susceptibility gene
has been mapped to human chromosome 1p13–q32 [23]. These re-
sults indicate that KITENIN is located at a human chromosome lo-
cus, which is deleted, mutated or rearranged in several types of
human cancer. In this study, KITENIN expression was higher in
the tumors and metastatic lymph nodes than in the adjacent
mucosal tissues and non-metastatic lymph nodes from patients
with locally advanced HNSCC. KITENIN-overexpressing SCC VII
cells exhibited increased invasiveness, migration, and proliferation
in vitro. Moreover, syngeneic mice given KITENIN-overexpressing
SCC VII cells showed more increased tumorigenicity and lung
metastasis compared with control syngeneic mice given vector-
transfected SCC VII cells. Therefore, our present results indicate
that KITENIN participates in the tumor progression and metastasis
in SCC as well as in CRC and bladder cancer [9,11–13].
Cellular invasion is stimulated in target cells by a variety of
extracellular signals including extracellular matrix, soluble growth
factors and chemokines [2]. Activation of the AP-1 transcription
factor complex is a universal response of most mammalian cells
to a broad range of stimuli and the AP-1 activity is increased in a
large number of tumors and transformed cell lines [24,25]. Re-
Fig. 1. Expression of KAI1 C-terminal interacting tetraspanin (KITENIN) and KAI1 in resected tissues from head and neck squamous cell carcinoma (HNSCC) patients. (A)
Densitometric analyzes of RT-PCR for KITENIN in HNSCC. Each KITENIN level was normalized with respect to the corresponding actin level. KITENIN mRNA expression was
increased in tumors compared with adjacent mucosa (adj-M) from 8 HNSCC patients (left), while signiﬁcantly elevated in metastatic lymph nodes (m-LN) more than non-
metastatic lymph nodes (n-LN) from 4 HNSCC patients (right). (B) Representative immunoblotting results of KITENIN and KAI1 expression among the resected tissues from 2
HNSCC patients. KAI1 expression inversely correlated with that of KITENIN between adj-M and tumor tissues, but not between n-LN and m-LN. (C) Densitometric analyzes of
immunoblot for KITENIN in HNSCC. Each KITENIN level was normalized with respect to the corresponding actin level. KITENIN expression was increased in tumors compared
with adj-M from 9 HNSCC patients (left), while signiﬁcantly higher in m-LN than that of n-LN from 6 HNSCC patients (right). (D) Densitometric analyzes of immunoblot for
KAI1 in HNSCC. Each KAI1 level was normalized with respect to the corresponding actin level. KAI1 expression was decreased in tumors compared with adj-M from 6 HNSCC
patients (left), while elevated in m-LN than that of n-LN from 4 HNSCC patients (right).
714 J.K. Lee et al. / FEBS Letters 583 (2009) 711–717cently, we found that in CRC cells, KITENIN served as a scaffolding
molecule that simultaneously recruited both Dishevelled and PKCd
to form a complex that stimulated ERK/AP-1 via a PKCd component
and controlled the invasiveness, and that KITENIN expression was
signiﬁcantly higher in advanced stage CRC tissues [12]. In this
study, we observed that the expressions of some AP-1 target genes
were higher in the KITENIN-transfected SCC VII cells. This ﬁnding
suggests that KITENIN could enhance the progression of SCC as a
result of activation of the AP-1 signal transduction pathway.HNSCC is characterized by a marked propensity for local inva-
sion and lymph node metastasis. Understanding the molecular
mechanisms that mediate SCC invasion and metastasis may enable
the identiﬁcation of novel therapeutic targets for the management
of tumor dissemination. Invasion and metastasis are complex pro-
cesses in which many molecules identiﬁed interact with one an-
other in enabling squamous cancer cells to disseminate from
their primary site [3]. One is that signal transduction elements
for increased proteolytic degradation of matrix components, which
Fig. 2. KITENIN enhances cell invasion, migration and proliferation of murine squamous cancer cells (SCC VII). (A) Establishment of the stably KITENIN-transfected SCC VII
(SCC VII/KITENIN) polyclonal cells. (B) Invasion assay of SCC VII cells using ﬁbronectin as a chemoattractant. Invading cells were larger in the KITENIN-transfected SCC VII cells
than in the empty vector-transfected SCC VII cells (left). Stained invading cells were counted and are represented as a bar graph between groups (right) (mean ± SEM, n = 3;
**p < 0.01). (C) The effects of the overexpressed KITENIN on cell migration. The empty vector- or KITENIN-transfected SCC VII cells were subjected to a wound healing assay
(left), and cell migration are displayed as relative healing distances measured in six random sites (right). Values are mean ± SEM for three independent experiments
(**p < 0.01). Cell migration was markedly increased in the KITENIN-transfected SCC VII cells. (D) The effects of the overexpressed KITENIN on cell proliferation. The absorbance
indicating proliferating viable cells was higher in the KITENIN-transfected SCC VII cells (n = 3, mean ± SEM, *p < 0.05).
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heterodimer complexes with ﬁbronectin and activates Fyn, which,
in turn, activates a matrix-degrading pathway involving urokinase
plasminogen activator, MMP-3, and MMP-9. The other is that sig-
nal transduction elements for enhanced cell motility; ligand bind-
ing to the epidermal growth factor receptor induces a sequential
downstream signaling in which actin-binding proteins, calcium,
and protein kinase C serve to increase cell motility through adhe-
sion and actin cytoskeleton alterations. In addition, it was reported
that the immunohistochemical KAI1 staining was decreased in tu-
mor tissues from oral and esophageal SCC patients [14–16]. In this
study, KAI1 expression inversely correlated with that of KITENINbetween normal adjacent mucosa and tumor tissues, but not be-
tween non-metastatic and metastatic lymph nodes. Unexpectedly,
compared with non-metastatic lymph nodes, an elevated level of
KAI1 but not signiﬁcant was observed in metastatic lymph nodes.
Although, the number of patients in our present analyzes is small,
these results suggest that the expression level of KITENIN, a tumor
metastasis-enhancing gene, is more reliable molecular marker for
the detection of lymph node metastasis from HNSCC patients
rather than that of KAI1, a tumor metastasis suppressor gene.
Therefore, in addition to epidermal growth factor receptor, our
present results suggest that the KITENIN/AP-1 axis also partici-
pates in SCC invasion and metastasis as another signal transduc-
Fig. 3. Promoting effects of the overexpressed KITENIN on in vivo tumor growth and distant metastasis. (A) Transfected SCC VII cells were injected subcutaneously into the
right ﬂank of syngeneic mice and tumor size was measured daily. Tumor growths were increased in the KITENIN-transfected SCC VII-injected C3H/HeJ syngeneic mice
compared to the vector-transfected SCC VII-injected mice (n = 6, mean ± SEM, **p < 0.01). (B) The number of metastatic nodule was signiﬁcantly increased in the KITENIN-
group more than that of vector-group. (C) H & E stained metastasized lung tissue from the KITENIN-transfected SCC VII-injected C3H/HeJ syngeneic mice. The representative
tumor cell nest invading the pleura (a thin arrow) and alveoli (a thick arrow) was shown (40). Dyskeratosis, frequent mitosis, coarse chromatin, and nuclear pleomorphism
were found in a high-power ﬁeld view of pleural metastatic tissue (inlet, H & E stain, 400).
Fig. 4. Increased expressions of AP-1 target genes in the KITENIN-transfected SCC
VII cells. Expressions of cyclin D1, MMP-1, COX-2, and CD44 were higher in the
KITENIN-transfected SCC VII cells.
716 J.K. Lee et al. / FEBS Letters 583 (2009) 711–717tion element for enhanced cell motility, and raising the possibility
that KITENIN-knockdown strategy has the therapeutic potential for
inhibiting the distant metastasis in SCC.Acknowledgments
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